Expect the Unexpected-First Case of Congenital Rubella Syndrome in Israel in 20 Years: A Case Report.

congenital infection neonatal brain rubella newborn vaccination

Journal

Journal of the Pediatric Infectious Diseases Society
ISSN: 2048-7207
Titre abrégé: J Pediatric Infect Dis Soc
Pays: England
ID NLM: 101586049

Informations de publication

Date de publication:
31 Dec 2021
Historique:
received: 01 02 2021
accepted: 17 04 2021
pubmed: 27 7 2021
medline: 5 1 2022
entrez: 26 7 2021
Statut: ppublish

Résumé

Congenital rubella syndrome (CRS) is a devastating condition associated with significant morbidity. Due to universal vaccination programs, it is currently a rare condition, especially in developed countries. We report an infant born in Israel to a foreign worker from the Philippines who presented with a blueberry muffin rash immediately after birth. Initial workup revealed sonographic brain anomalies, abnormal hearing tests, and a patent ductus arteriosus. CRS was subsequently confirmed by laboratory diagnosis. Rubella virus genotype 1E was detected in the infant's nasopharyngeal swab and urine samples. This was the first case of CRS in Israel in 20 years, emphasizing the need to "think outside the box" when dealing with infants of mothers who are foreign workers, refugees, or visitors of foreign relatives, in which rubella immune status is unknown. Additionally, public health authorities should consider the routine assessment of rubella immunity status of foreign workers in order to avoid such tragic, preventable diseases. We present a case of congenital rubella syndrome - rarely seen in developed countries. This emphasis the need to "think out of the box" when dealing with infants of mothers who come from countries in which the vaccination program is not well established.

Identifiants

pubmed: 34309677
pii: 6328553
doi: 10.1093/jpids/piab030
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1105-1107

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Michal Molad (M)

Neonatal Intensive Care Unit, Carmel Medical Center, Haifa, Israel.
Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Ayala Gover (A)

Neonatal Intensive Care Unit, Carmel Medical Center, Haifa, Israel.
Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Moshe Ephros (M)

Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Pediatric Department, Carmel Medical Center, Haifa, Israel.

Karen Lavie-Nevo (K)

Neonatal Intensive Care Unit, Carmel Medical Center, Haifa, Israel.
Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Dan Waisman (D)

Neonatal Intensive Care Unit, Carmel Medical Center, Haifa, Israel.
Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Tal Levin (T)

Central Virology Laboratory, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel.

Yara Kanaaneh (Y)

Central Virology Laboratory, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel.

Victoria Indenbaum (V)

Central Virology Laboratory, Ministry of Health, Sheba Medical Center, Tel-Hashomer, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH